BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luciani M, Bentivegna E, Spuntarelli V, Lamberti PA, Cacioli G, Del Porto F, Sesti G, Martelletti P, De Biase L. Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? J Med Virol 2021;93:1882-4. [PMID: 33247596 DOI: 10.1002/jmv.26701] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Asadzadeh Aghdaei H, Bentivegna E, Martelletti P, Petrosillo N, Zali MR. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? Front Med (Lausanne) 2021;8:775063. [PMID: 34966759 DOI: 10.3389/fmed.2021.775063] [Reference Citation Analysis]
2 Bader N, Khattab M, Farah F. Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report. J Med Case Rep 2021;15:392. [PMID: 34284812 DOI: 10.1186/s13256-021-02958-4] [Reference Citation Analysis]
3 Lo Muzio L, Ambosino M, Lo Muzio E, Quadri MFA. SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature. Int J Environ Res Public Health 2021;18:11001. [PMID: 34682746 DOI: 10.3390/ijerph182011001] [Reference Citation Analysis]
4 Bird PW, Badhwar V, Kennedy B, Ladani S, Tang JW. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients. J Med Virol 2021;93:4585-91. [PMID: 33595119 DOI: 10.1002/jmv.26886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Siqueira JD, Goes LR, Alves BM, da Silva ACP, de Carvalho PS, Cicala C, Arthos J, Viola JPB, Soares MA. Distinguishing SARS-CoV-2 bonafide re-infection from pre-existing minor variant reactivation. Infect Genet Evol 2021;90:104772. [PMID: 33592317 DOI: 10.1016/j.meegid.2021.104772] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Kapoor R, Nair RK, Nayan N, Bhalla S, Singh J. Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series. SN Compr Clin Med 2021;:1-5. [PMID: 33585797 DOI: 10.1007/s42399-021-00790-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Julian K, Shah N, Banjade R, Bhatt D. Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient. BMJ Case Rep 2021;14:e243692. [PMID: 34315745 DOI: 10.1136/bcr-2021-243692] [Reference Citation Analysis]
8 Ren X, Ren X, Lou J, Wang Y, Huang Q, Shi Y, Deng Y, Li X, Lu L, Yan S, Wang Y, Luo L, Zeng X, Yao X, Jin Y. A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR. EClinicalMedicine 2021;34:100839. [PMID: 33898952 DOI: 10.1016/j.eclinm.2021.100839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tang Y, Hu L, Liu Y, Zhou B, Qin X, Ye J, Shen M, Wu Z, Zhang P. Possible mechanisms of cholesterol elevation aggravating COVID-19. Int J Med Sci 2021;18:3533-43. [PMID: 34522180 DOI: 10.7150/ijms.62021] [Reference Citation Analysis]
10 Bentivegna E, Luciani M, Arcari L, Santino I, Simmaco M, Martelletti P. Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study. Int J Environ Res Public Health 2021;18:1003. [PMID: 33498701 DOI: 10.3390/ijerph18031003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Bagheri N, Montazeri H. On BCG Vaccine Protection from COVID-19: A Review. SN Compr Clin Med 2021;:1-11. [PMID: 33748676 DOI: 10.1007/s42399-021-00835-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zayet S, Royer PY, Toko L, Pierron A, Gendrin V, Klopfenstein T. Recurrence of COVID-19 after recovery ? A case series in health care workers, France. Microbes Infect 2021;23:104803. [PMID: 33667643 DOI: 10.1016/j.micinf.2021.104803] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang K, Wu JJ, Xin-Zhang, Zeng QX, Zhang N, Huang WJ, Tang S, Wang YX, Kong WJ, Wang YC, Li YH, Song DQ. Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage. Bioorg Chem 2021;115:105196. [PMID: 34333425 DOI: 10.1016/j.bioorg.2021.105196] [Reference Citation Analysis]
14 Zaffina S, Lanteri P, Gilardi F, Garbarino S, Santoro A, Vinci MR, Carsetti R, Scorpecci A, Raponi M, Magnavita N, Camisa V. Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature. Front Hum Neurosci 2021;15:666468. [PMID: 34456694 DOI: 10.3389/fnhum.2021.666468] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Salehi-Vaziri M, Jalali T, Farahmand B, Fotouhi F, Banifazl M, Pouriayevali MH, Sadat Larijani M, Afzali N, Ramezani A. Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran. Eur J Clin Microbiol Infect Dis 2021;40:1713-9. [PMID: 33738620 DOI: 10.1007/s10096-021-04221-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Roberts AT, Piani F, Longo B, Andreini R, Meini S. Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature. Infect Dis (Lond) 2021;53:479-85. [PMID: 33849385 DOI: 10.1080/23744235.2021.1905174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
17 Hanioka Y, Morita R, Yamagami K, Yao S, Nakamura R, Nakamura T, Shimizu K, Yamaguchi T, Goto H. Recent Outpatient Services in General Internal Medicine: 6.4% of Symptomatic Patients Were Post-Acute COVID-19. Int J Gen Med 2021;14:7391-7. [PMID: 34754220 DOI: 10.2147/IJGM.S330525] [Reference Citation Analysis]
18 Ljungquist O, Lundgren M, Iliachenko E, Månsson F, Böttiger B, Landin-Olsson M, Wikén C, Rosendal E, Överby AK, Wigren BJ, Forsell MNE, Kjeldsen-Kragh J, Rasmussen M, Kahn F, Holm K. Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases. Infect Dis (Lond) 2021;:1-9. [PMID: 34878955 DOI: 10.1080/23744235.2021.2013528] [Reference Citation Analysis]
19 Aurilio C, Sansone P, Paladini A, Barbarisi M, Coppolino F, Pota V, Pace MC. Multidrug Resistence Prevalence in COVID Area. Life (Basel) 2021;11:601. [PMID: 34201519 DOI: 10.3390/life11070601] [Reference Citation Analysis]